KRAS and non-small cell lung carcinoma: During the past few years, several gene aberrations have been identified as oncogenic drivers in NSCLC, including epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) [2].